PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.06%
Revenue growth under 50% of ADI's 6.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-2.03%
Negative gross profit growth while ADI is at 7.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
6.44%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
6.44%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
3.80%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
5.13%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
5.26%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.23%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.50%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
194294.01%
Dividend growth above 1.5x ADI's 1.58%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-40.03%
Negative OCF growth while ADI is at 11.10%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-47.18%
Negative FCF growth while ADI is at 11.09%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-5.84%
Negative 10Y revenue/share CAGR while ADI stands at 228.13%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
28.37%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
70.09%
3Y revenue/share CAGR above 1.5x ADI's 35.40%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
61.20%
10Y OCF/share CAGR under 50% of ADI's 201.82%. Michael Burry would worry about a persistent underperformance in cash creation.
49.82%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
24.02%
3Y OCF/share CAGR under 50% of ADI's 342.88%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
112.59%
Net income/share CAGR at 50-75% of ADI's 163.27%. Martin Whitman might question if the firm’s product or cost base lags behind.
11.83%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
213.01%
3Y net income/share CAGR above 1.5x ADI's 94.94%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
175.31%
Below 50% of ADI's 663.08%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
2.48%
Below 50% of ADI's 56.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
13.01%
Below 50% of ADI's 26.25%. Michael Burry suspects a serious short-term disadvantage in building book value.
37.38%
Dividend/share CAGR of 37.38% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
40.20%
Dividend/share CAGR of 40.20% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
35.49%
3Y dividend/share CAGR of 35.49% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-13.94%
Firm’s AR is declining while ADI shows 8.26%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.93%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.53%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.79%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
84.64%
Debt growth of 84.64% while ADI is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-5.12%
Our R&D shrinks while ADI invests at 3.76%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
4.17%
SG&A growth well above ADI's 0.36%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.